CIK 0001509261
- Non-accelerated filer
- Smaller reporting company
Rezolute, Inc.
Sign in to watch- Ticker
- RZLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 273440894
- Phone
- +1 650-206-4507
- Business address
- 275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY, CA, 94065
- Former names
- AntriaBio, Inc., FITS MY STYLE INC
- 4 Open-market buy Chief Medical Officer bought 7,500 shares at an average $2.69 ($20,138)
- 4 Open-market buy CFO bought 3,000 shares at an average $3.22 ($9,668)
- 4 Open-market buy Chief Medical Officer bought 500 shares at $2.55 ($1,275)
- 4 Open-market buy Director bought 3,927,126 shares at an average $4.33 ($17,000,003)
- 4 Open-market buy CFO bought 20,000 shares at $1.69 ($33,830)
- 4 Open-market buy Chief Medical Officer bought 10,000 shares at $1.88 ($18,800)
- 4/A Open-market buy Chief Medical Officer bought 500 shares at $1.85 ($925)
- 4 Open-market buy Director bought 115,450 shares at an average $3.20 ($369,858)
- 4 Open-market buy Chief Medical Officer bought 500 shares at $1.85 ($925)
- 4 Open-market buy CFO bought 50,000 shares at $1.93 ($96,345)
- 4 Open-market buy CEO bought 5,000 shares at $1.68 ($8,400)
- 4 Open-market buy Chief Medical Officer bought 8,000 shares at an average $1.69 ($13,540)
- 4 Open-market buy Chief Medical Officer bought 7,000 shares at $1.31 ($9,142)
- 4 Open-market buy CFO bought 50,900 shares at an average $1.31 ($66,741)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 11 · 208 filings